| Efficacy of immune checkpoint inhibitors in patients with mismatch repair-deficient or microsatellite instability-high metastatic colorectal cancer: analysis of three phase-II … L Cancanelli, M Rivano, L Di Spazio, M Chiumente, D Mengato, ... Cureus 13 (11), 2021 | 17 | 2021 |
| A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia A Messori, M Rivano, D Mengato, L Cancanelli, L Di Spazio, ... Leukemia & Lymphoma 63 (5), 1261-1264, 2022 | 16 | 2022 |
| The degree of programmed death-ligand 1 (PD-L1) positivity as a determinant of outcomes in metastatic triple-negative breast cancer treated with first-line immune checkpoint … L Di Spazio, M Rivano, L Cancanelli, M Chiumente, D Mengato, ... Cureus 14 (1), 2022 | 16 | 2022 |
| Medical therapy, radiofrequency ablation, or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through the shiny method S Trippoli, L Di Spazio, M Chiumente, A Messori Cureus 14 (2), 2022 | 9 | 2022 |
| Application of the Ipdfromkm-shiny method to compare the efficacy of novel treatments aimed at the same disease condition: a report of 14 analyses A Messori, V Damuzzo, M Rivano, L Cancanelli, L Di Spazio, A Ossato, ... Cancers 15 (6), 1633, 2023 | 8 | 2023 |
| Survival in patients with relapsed-refractory multiple myeloma: indirect comparison of six new treatments L Cancanelli, M Rivano, L Di Spazio, M Chiumente, D Mengato, ... Preprints, 2022 | 5 | 2022 |
| Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. L Di Spazio, L Cancanelli, M Rivano, M Chiumente, D Mengato, ... European Review for Medical & Pharmacological Sciences 25 (4), 2021 | 5 | 2021 |
| Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: Analysis of 4 clinical studies M Rivano, L Cancanelli, LD Spazio, M Chiumente, D Mengato, A Messori Immunotherapy 13 (2), 95-101, 2021 | 4 | 2021 |
| Newly introduced anti-cancer drugs: description of an original evidence-based approach that indirectly compares multiple treatments sharing the same clinical indication and … A Messori, P Baldo, L Cancanelli, M Chiumente, V Damuzzo, L Di Spazio, ... Open Science Framework, url https://osf. io/u6bt2/(access 24 February 2022), 2022 | 3 | 2022 |
| Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: Indirect comparison of three randomized phase-III trials M Rivano, L Cancanelli, L Di Spazio, D Mengato, M Chiumente, ... World Journal of Urology 40 (11), 2609-2615, 2022 | 2 | 2022 |
| Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy D Mengato, L Cancanelli, L Di Spazio, M Rivano, M Chiumente, ... International Journal of Clinical Pharmacology and Therapeutics 60 (8), 370, 2022 | 2 | 2022 |
| Evaluation of maintenance treatment with PARP inhibitors in ovarian carcinoma patients responding to platinum therapy: Use of restricted mean survival time as an index of efficacy L Cancanelli, D Mengato, L Di Spazio, M Rivano, M Chiumente, ... International Journal of Clinical Pharmacology and Therapeutics 60 (1), 32, 2022 | 2 | 2022 |
| Are the Voices of Women and Men Equally Represented in Ethics Committees P Mosconi, L Lionello, LD Spazio, L Alberghini An Italian Survey. J Clinic Res Bioeth 3 (129), 2, 2012 | 2 | 2012 |
| Survival in patients with relapsed-refractory multiple myeloma: Indirect comparison of six new treatments L Cancanelli, M Rivano, L Di Spazio, M Chiumente, D Mengato, ... Hematology Reports 15 (1), 57-65, 2023 | 1 | 2023 |
| Application of artificial intelligence for an early comparison of efficacy between new cancer drugs. V Damuzzo, M Rivano, P Baldo, L Cancanelli, L Di Spazio, A Ossato, ... Recenti Progressi in Medicina 113 (11), 680-687, 2022 | 1 | 2022 |
| Hand hygiene for healthcare workers: did we need COVID-19 to raise awareness of proper disinfection practice? D Mengato, L Di Spazio European Journal of Hospital Pharmacy 29 (5), 302-302, 2022 | 1 | 2022 |
| First-line chemoimmunotherapy versus chemotherapy in PD-L1-negative patients with non-small-cell lung cancer D Mengato, L Cancanelli, M Rivano, M Chiumente, LD Spazio, A Messori Immunotherapy 14 (11), 871-877, 2022 | 1 | 2022 |
| Survival in Real-World Patients Receiving Left Ventricular Assist Devices D Mengato, L di Spazio, A Messori The Annals of Thoracic Surgery 113 (1), 381, 2022 | 1 | 2022 |
| Efficacy of ICD in ischemic cardiac disease determined by reconstructing patient-level data from Kaplan-Meier survival curves A Messori, M Rivano, L Di Spazio, S Trippoli Medical Research Archives 12 (3), 2024 | | 2024 |
| Applicazione dell’intelligenza artificiale per un precoce confronto di efficacia tra nuovi farmaci oncologici V Damuzzo, M Rivano, P Baldo, L Cancanelli, L Di Spazio, A Ossato, ... Recenti Progressi in Medicina 113 (11), 680-687, 2022 | | 2022 |
